Reproducible differentiation and characterization of neurons from mouse embryonic stem cells.
Cell-based models
Mouse embryonic stem cells
Neurological disorders
Neuronal differentiation
Journal
MethodsX
ISSN: 2215-0161
Titre abrégé: MethodsX
Pays: Netherlands
ID NLM: 101639829
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
07
2020
accepted:
17
09
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
22
10
2020
Statut:
epublish
Résumé
Investigation on the effects of disease-associated mutations on neurodevelopment is an essential approach to understand the molecular basis of neurological disorders and can be achieved by generating suitable animal models. However, some of the mutations preclude development of animal models, leaving cell-based models as the only options. Mouse embryonic stem cells (mESCs) are attractive because of the well-established technologies for introducing disease-associated mutations and the feasibility of investigating the abnormalities during different stages of neurogenesis. Importantly, such transgenic mESCs enable large-scale screening and identification of the most promising small molecules and/or drug candidates before undertaking expensive animal studies. Although neuronal differentiation from mESCs is one of the earliest methods to be developed, we observed that the published as well as publicly available methods did not yield neurons consistently. Here, we describe a 16-day differentiation protocol that consistently induced differentiation of mESCs into neurons. This step-wise protocol enables monitoring of the neuronal differentiation process at different stages as well as characterization using the markers for immature and mature neurons by using immunocytochemistry and quantitative real-time PCRs.•Development of a method for differentiating mouse ES cells into neurons.•Differentiating the mouse ES cells into embryoid bodies prior to induction of neuronal differentiation results in better neuron formation.
Identifiants
pubmed: 33083240
doi: 10.1016/j.mex.2020.101073
pii: S2215-0161(20)30293-4
pmc: PMC7551330
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101073Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Biomol Ther (Seoul). 2014 Jul;22(4):267-74
pubmed: 25143803
Mol Cell Biol. 2002 Apr;22(7):2124-35
pubmed: 11884600
Mamm Genome. 2019 Jun;30(5-6):90-110
pubmed: 30820643
Curr Opin Neurobiol. 2011 Feb;21(1):197-203
pubmed: 20832285
Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3A
pubmed: 18432653
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Curr Genomics. 2007 Nov;8(7):429-44
pubmed: 19412416
Stem Cells Int. 2016;2016:4379425
pubmed: 26798355
Nat Biotechnol. 2003 Feb;21(2):183-6
pubmed: 12524553
Curr Pharm Des. 2012;18(8):1131-47
pubmed: 22288400